Evaluation of a Novel Boron-Containing α-d-Mannopyranoside for BNCT

Boron neutron capture therapy (BNCT) is a unique anticancer technology that has demonstrated its efficacy in numerous phase I/II clinical trials with boronophenylalanine (BPA) and sodium borocaptate (BSH) used as (10)B delivery agents. However, continuous drug administration at high concentrations i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsurubuchi, Takao, Shirakawa, Makoto, Kurosawa, Wataru, Matsumoto, Kayo, Ubagai, Risa, Umishio, Hiroshi, Suga, Yasuyo, Yamazaki, Junko, Arakawa, Akihiro, Maruyama, Yutaka, Seki, Takuya, Shibui, Yusuke, Yoshida, Fumiyo, Zaboronok, Alexander, Suzuki, Minoru, Sakurai, Yoshinori, Tanaka, Hiroki, Nakai, Kei, Ishikawa, Eiichi, Matsumura, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290312/
https://www.ncbi.nlm.nih.gov/pubmed/32455737
http://dx.doi.org/10.3390/cells9051277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290312/
https://www.ncbi.nlm.nih.gov/pubmed/32455737
http://dx.doi.org/10.3390/cells9051277

Ejemplares similares